Anticardiolipin syndrome: antiphospholipid syndrome.

North Am 2000;26:215–27. 14 Savill J. Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull 1997;53:491–508. 15 Elkon KB. Apoptosis in SLE – too little or too much? Review. Clin Exp Rheumatol 1994;12:553–9. 16 Drappa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB. Fas gene-mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 1996; 335:1643–9. 17 Vaishnaw AK, Sullivan KE, Elkon KB. The Canale-Smith syndrome. Reply. N Engl J Med 1997;336:1457–8. 18 Rovere P, Sabbadini MG, Fazzini F, Bondanza A, et al. Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity. Arthritis Rheum 2000;43: 1663–72. 19 Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998;19:56–9. 20 Voll RE, Roth E, Herrmann M, Fehr H, et al. Histone-specific Th clones derived from systemic lupus-erythematosus patients display a Th0-like or Th1-like cytokine secretion pattern. Arthritis Rheum 1996;39: 1326. 21 Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Review. Immunobiology 1998;199:265–85. 22 Korb LC, Ahearn JM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 1997;158:4525–8. 23 Pickering MC, Walport MJ. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford) 2000;39:133–41. 24 Taylor PR, Carugati A, Fadok VA, Cook HT, et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000;192:359–66.